Log in
Enquire now
Melinta Therapeutics

Melinta Therapeutics

Melinta Therapeutics is a small Molecule Discovery founded in 2013.

OverviewStructured DataIssuesContributors

Contents

melinta.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Pharmaceutical industry
Pharmaceutical industry
Biomedical engineering
Biomedical engineering
Location
Morristown, New Jersey
Morristown, New Jersey
United States
United States
New Haven, Connecticut
New Haven, Connecticut
B2X
B2B
B2B
0
AngelList URL
angel.co/melinta-th...rapeutics-1
Number of Employees (Ranges)
51 – 200
Full Address
44 Whippany Rd, Suite 280, Morristown, New Jersey 07960, US
Investors
EuclidSR Partners
EuclidSR Partners
0
ABS Ventures
ABS Ventures
MedImmune Ventures
MedImmune Ventures
Axiom Ventures
Axiom Ventures
Warburg Pincus
Warburg Pincus
Oxford Bioscience Partners
Oxford Bioscience Partners
Sanofi
Sanofi
Founded Date
2013
0
Total Funding Amount (USD)
25,000,000
Latest Funding Round Date
January 25, 2009
Patents Assigned (Count)
20
Wellfound ID
melinta-therapeutics-1
Country
United States
United States

Other attributes

Company Operating Status
Active
Public/Private
Private
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Melinta Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.